Active Stocks

Fri Mar 06 2026 15:59:41

Eternal share price
232.15 -3.39%

HDFC Bank share price
857.10 -2.39%

Bharat Electronics share price
468.35 1.82%

Tata Steel share price
198.50 -1.05%

Reliance Industries share price
1,405.20 1.11%

Business News > Mint Authors > Ch Unnikrishnan

Ch Unnikrishnan

ARTICLES BY CH UNNIKRISHNAN

SRF acquires pharma propellant business of DuPont

1 min read . 01 Jan 2015

Domestic sales, which includes the acquired Elder Pharma business, grew 49%, said the company.

Torrent Pharma Q2 profit jumps 75% to Rs198 crore

1 min read . 05 Nov 2014

The Intellectual Property Appellate Board (IPAB) is India’s appellate tribunal for patent cases.

Reconstitute IPAB recruitment body with chairman as head: Madras HC

1 min read . 02 Sept 2014

Industry lobbies, which had come out with their own guidelines in this regard, had also proposed setting up of internal ethics panel or ombudsmen both at the industry level and at an individual company level to keep a tab on unethical practices. Photo: Sneha Srivastava/Mint (Sneha Srivastava/Mint)

Drug industry divided over govt move on statutory marketing code

2 min read . 27 Aug 2014

A PIL says the composition of the selection panel that chooses IPAB members violates the guidelines laid down by the Supreme Court.

Govt not to pick IPAB vice-chief until HC decision on PIL

1 min read . 15 Aug 2014

Sun Pharma’s results are almost in the expected line as analysts had estimated a flat growth in profit as the US sales was impacted due to price adjustment in Taro Pharma portfolio. Photo: Hemant Mishra/Mint

Sun Pharma posts Rs1,391 crore profit in Q1

3 min read . 13 Aug 2014

Key budget recommendations include a rise in FDI limit in medical insurance to 49% and four more medical institutions of the status of AIIMS. Photo: Pradeep Gaur/Mint

Budget offers marginal solution to India’s unmet healthcare access

3 min read . 11 Jul 2014

EU’s Competion Commission had found the firms guilty of an alleged settlement agreement with a French drug maker to delay the launch of a copy of hypertension drug Perindopril. Photo: Mint

Generic drug makers to challenge EU anti-trust fine

2 min read . 10 Jul 2014

Uday Kotak wins the EY World Entrepreneur of the year award

1 min read . 08 Jun 2014

Venus Remedies had been granted European patents for three other drug candidates in the same area earlier.

Venus Remedies gets European patent for drug-resistant infection medicine

1 min read . 03 Jun 2014

The company had set an annual growth target of at least 25% since 2012, and crossed `1,271 crore in sales in the year ended 31 March 2014. Photo: Mint

Deepak Nitrite plans rights issue to fund expansion, pare debt

3 min read . 22 May 2014

Lupin may drop some brands or put them on the block. These brands are typically the ones that generate revenue of less than `5 crore and belong to a category called complementary therapies, which are drugs that doctors prescribe in addition to the main treatment. Photo: Bloomberg

Lupin to exit from weaker brands, to buy stronger ones

3 min read . 13 May 2014

Orchid has had a total debt of about $500 million as on June 2013.

Lenders approve Orchid Chemical’s ₹3,547 cr CDR plan

1 min read . 15 Mar 2014

The group has made an initial investment of about `17 crore (€2 million), said BASF’s global president (Biological and Effect Systems Research), Harald Lauke, in an interview.

BASF opens new global research centre in Mumbai

1 min read . 07 Mar 2014

UN agency Unicef last year launched the global polio eradication initiative (GPEI) endgame strategic plan 2013-2018. Photo: AFP

Serum Institute, Bilthovan to slash polio vaccine prices

1 min read . 04 Mar 2014

Piramal Enterprises had proposed new business plans in banking, insurance, information technology and security solutions, among other areas, to grow bigger. Photo: Mint

Piramal Enterprises lists potential investment areas

4 min read . 03 Mar 2014

Alongside manufacturing generic medicines, the chemists’ entity has ventured into logistics and cold-chain management and market research linked to the pharma retail market. Photo: Bloomberg

Rift widens in pharma industry as retailers enter manufacturing arena

3 min read . 23 Jan 2014

Ranbaxy paid a fine of $500 million to US department of justice for alleged malpractices in documentation on manufacturing process, and has signed a consent decree (CD) with the US FDA to become compliant with the manufacturing regulations. Photo: Pradeep Gaur/Mint (Pradeep Gaur/Mint)

Ranbaxy’s US plant gets FDA clearance

2 min read . 10 Oct 2013

FDI inflows registered 38% decline to $22.42 billion in 2012-13 compared to the previous year’s $35.12 billion. Photo: Mint (Mint)

Policies on FDI, taxes have undermined India’s image: Sanofi chief

1 min read . 01 Oct 2013

At least 700,000 people in Puducherry will be screened to detect and treat for these diseases. Photo: Mint (Mint )

Abbott, Puducherry, govt join hands to fight non-communicable diseases

1 min read . 29 Mar 2013